Patents
Patents for C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
12/2008
12/23/2008US7468435 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
12/03/2008CN101314595A Aromatic hydrocarbons connected multi-polyamine large-ring derivants, preparation method and medical use thereof
12/02/2008US7459551 Method for preparing cyclic compounds
11/2008
11/25/2008US7456206 Biaryl heterocyclic compounds and methods of making and using the same
11/12/2008EP1989180A1 Modified amino acids
11/12/2008CN101304982A Process for the preparation of benzotriazepine derivatives
11/06/2008US20080275097 Non-nucleoside reverse transcriptase inhibitors
11/05/2008EP1322626B1 Process for preparation of n-1 protected n ring nitrogen containing cyclic polyamines and products thereof
10/2008
10/16/2008WO2008123779A1 Trisubstituted triazamacrocycli c compounds and their use as contrast agents
10/09/2008US20080249080 Benzodiazepine Derivatives and Uses Thereof on Medical Field
10/01/2008EP1973887A1 Aza heterocyclics for the treatment of malaria or aids
09/2008
09/25/2008WO2008114864A1 Iron complex and method for producing polymer using the iron complex as catalyst
09/24/2008EP1971582A1 Macrocyclic factor viia inhibitors useful as anticoagulants
09/10/2008EP1966169A2 Compositions and methods for the inhibition of phospholipase a2
09/04/2008US20080214814 Capable of maintaining stability at high temperatures, high pH, under acidic and highly oxidative conditions in the presence of a transition metal; converting methane to methanol; neutralizing nuclear waste treatment; preventing degradation of optical components; metal extraction
08/2008
08/28/2008US20080207914 Reacting dicyanamide salt, azide compound, solvent and water; heating
08/14/2008WO2008096001A1 Hcv inhibiting macrocyclic phenylcarbamates
08/14/2008CA2677015A1 Hcv inhibiting macrocyclic phenylcarbamates
08/06/2008EP1951046A2 Methods to enhance chemotherapy
08/05/2008CA2466934C Improved purification of 4, 4'(5')-di-t-butylcyclohexano-18-crown-6
07/2008
07/30/2008EP1948624A2 Process for the preparation of benzo[e][1,2,4]triazepin-2-one derivatives
07/03/2008WO2008079836A2 Macrocyclic factor viia inhibitors useful as anticoagulants
07/03/2008CA2673598A1 Macrocyclic factor viia inhibitors useful as anticoagulants
06/2008
06/24/2008US7390861 Ancillary ligand and the transition metal form a metallocycle having at least five primary atoms, counting any pi -bound cyclopentadienyl group in the metallocycle as two primary atoms; olefin polymerization
06/19/2008US20080145311 Chelating agents with lipophilic carriers
06/10/2008US7385053 Functionalized compositions for improved immobilization
06/05/2008DE60129697T2 Kondensierte azepinderivate und ihre verwendung als antidiuretisches mittel Condensed azepine derivatives and their use as antidiuretic agent
05/2008
05/29/2008US20080124270 Compounds Useful as Metal Chelators
05/08/2008US20080107606 Bifunctional chelators for sequestering lanthanides
05/06/2008US7368100 Backbone-substituted bifunctional DOTA ligands, complexes and compositions thereof, and methods of using same
05/02/2008WO2008051017A1 A cleavage agent selectively acting on soluble assembly of amyloidogenic peptide or protein
04/2008
04/29/2008US7365197 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines
02/2008
02/20/2008EP1289968B1 Cyclic urea compounds and preparation thereof
02/14/2008US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease
02/07/2008US20080033167 Compositions and methods for synthesizing heterocyclic therapeutic compounds
02/07/2008US20080031823 Agents for therapy efficacy monitoring and deep tissue imaging
11/2007
11/29/2007WO2007135350A1 Benzotriazepinone derivatives
11/22/2007WO2007022523A3 Methods to enhance chemotherapy
11/15/2007WO2007128874A1 Biomolecule labeling reactants based on azacycloalkanes and conjugates derived thereof
11/15/2007WO2007128873A1 A method for the preparation of maleimido derivatives of biomolecule labeling reactants and conjugates derived thereof
11/15/2007WO2007074169A3 Compositions and methods for the inhibition of phospholipase a2
11/14/2007CN100348196C Benzotriazepines as gastrin and cholecystokinin receptor ligands
11/08/2007US20070258905 Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents
10/2007
10/18/2007WO2007117180A1 Azaheterocycles, combinatory library, focused library, pharmaceutical composition and methods for the production thereof
10/18/2007WO2007095980A8 Modified amino acids
08/2007
08/30/2007WO2007095980A1 Modified amino acids
08/29/2007EP1826199A1 Modified amino acids
08/09/2007US20070185093 Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands
08/01/2007EP1294698B1 Fused azepine derivatives and their use as antidiuretic agents
07/2007
07/05/2007WO2007076431A1 Macrocyclic factor viia inhibitors useful as anticoagulants
07/05/2007WO2007074171A1 Aza heterocyclics for the treatment of malaria or aids
07/05/2007CA2635359A1 Compositions and methods for synthesizing heterocyclic therapeutic compounds
07/05/2007CA2634794A1 Macrocyclic factor viia inhibitors useful as anticoagulants
06/2007
06/28/2007WO2007035430A3 Process for the preparation of benzo [e] [1,2,4] triazepin-2-one derivatives
06/21/2007WO2007069924A1 Deazapurine analogs of 4'-aza-l-nucleosides
06/21/2007WO2007069923A1 Deazapurine analogs of 1'-aza-l-nucleosides
05/2007
05/17/2007US20070111927 Peptoid compounds
04/2007
04/12/2007US20070082892 Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands
04/04/2007CN1308313C Fused azepine drivatives and their use as antidiuretic agents
03/2007
03/29/2007WO2007035430A2 Process for the preparation of benzo [e] [1,2,4] triazepin-2-one derivatives
03/29/2007WO2006078676A3 Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
03/29/2007US20070072792 Macrocyclic lactams and pharmaceutical use thereof
03/22/2007WO2006129120A9 Benzotriazepinone derivatives
03/06/2007US7186828 Cyclic urea compounds and preparation thereof
02/2007
02/22/2007CA2619828A1 Methods to enhance chemotherapy
02/13/2007US7176195 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia
02/01/2007WO2006129120A3 Benzotriazepinone derivatives
01/2007
01/24/2007CN1902182A Macrocyclic lactams and pharmaceutical use thereof
01/16/2007US7163935 Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same
01/10/2007CN1891694A Method for preparing 1,3-dialkyl-2-imidazolidinone and 1,5- dialkyl-(1,3,5)triazahepane-2,4-diketone
01/09/2007US7160854 Binaphthyl peptidomimetics for treating vancomycin resistant Staphylococcus aureas infections
12/2006
12/12/2006US7148219 Biaryl heterocyclic compounds and methods of making and using the same
12/07/2006WO2006129120A2 Benzotriazepinone derivatives
11/2006
11/23/2006US20060264426 Antiinfective agent, antiproliferation agent, antiinflammatory agent or prokinetics
09/2006
09/06/2006CN1273455C Process for preparation of N-1 protected N ring nitrogen -containing cyclic polyamines and products thereof
09/06/2006CN1273448C Method for preparing aryl alkyl hydrogen peroxide
08/2006
08/01/2006US7084280 Benzotriazol-1-yl-aminoacetonitrile compounds and their use in the control of parasite disease
07/2006
07/26/2006EP1682521A1 Macrocyclic lactams and pharmaceutical use thereof
07/25/2006US7081452 Diagnosis, therapy, image of celluloar disorders; antitumor agents
07/12/2006CN1263759C Improving method for preparing cross-bridge macrocylic compound
06/2006
06/20/2006US7064117 Anti-cancer 2,3-dihydro-1H-pyrrolo[3,2-f]quinoline complexes of cobalt and chromium
06/13/2006US7060818 Synthesis of macrocyclic tetraamido compounds and new metal insertion process
06/07/2006CN1258527C Method for preparing aryl alkyl hydrogen peroxide
05/2006
05/17/2006EP1656370A2 Biaryl heterocyclic compounds and methods of making and using the same
05/10/2006EP1208186B1 Composition and method for bleaching a substrate
04/2006
04/04/2006US7022717 Chemokine receptor binding heterocyclic compounds
03/2006
03/30/2006WO2005019211A3 Biaryl heterocyclic compounds and methods of making and using the same
03/29/2006EP1640368A2 Cyclic ureas and processes for their preparation
03/29/2006EP1064300A4 Peptide turn mimetics
03/29/2006CN1753849A Mono amine and diamine derivatives of cl-20
03/14/2006US7012140 substituted tetraazacyclododecane ligand containing a macrocyclic ring and a paramagnetic lanthanide metal ion coordinated to the tetraazacyclod odecane ligand; coordinated geometry adjusts the water exchange rate of the contrast agent
01/2006
01/31/2006US6992185 Inverse precipitation technique to produce the epsilon polymorph
01/05/2006US20060003993 Benzotriazepnes as gastrin and cholecystokinin receptor ligands
11/2005
11/29/2005US6969726 can be used as anti-proliferative agents and/or anti-infective agents that can be used without limitation as anti-inflammatory agents
09/2005
09/20/2005CA2125978C Improvements in chemical compounds
09/15/2005US20050203147 Biaryl heterocyclic compounds and methods of making and using the same
09/13/2005US6942966 Methods for processing chemical compounds having reactive functional groups
09/07/2005CN1217939C Compound of phycocyania of blue-green algae, its preparing method and usage
07/2005
07/07/2005US20050148566 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
06/2005
06/16/2005US20050130949 Antiproliferative agents; ATP-ase activity; e.g. 5,9,14-Trimethyl-4-undecyl-1,5,9,14-tetraazacycloheptadecan-2-one; budmunchiamine compounds
1 2 3 4 5 6 7 8